Yarrow Bioscience Stock Forecast
NASDAQ: YARWHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
YARW analyst consensus
Consensus (3 analysts)
none
Avg. price target
$57.00+189.19%
- Strong buy 0
- Buy 3
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 3 Wall Street analysts covering Yarrow Bioscience (2026-10-08), 3 rate the stock a buy or strong buy, 0 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "none". The average 12-month price target is $57.00, with a high estimate of $58.00 and a low estimate of $56.00. The average target implies upside of 189.2% from the current price of $19.71.
The spread between the highest and lowest targets is 3.6%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for YARW.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 0 | 0% |
| Buy | 3 | 100% |
| Hold | 0 | 0% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $56.00 | +184.12% |
| Average target | $57.00 | +189.19% |
| High target | $58.00 | +194.27% |